Yacine Abed, Guy Boivin. Oseltamivir Resistance in Human Influenza A(H5N1) and A(H7N9) Infections: a mini review. Open Forum Infectious Diseases, 2026
Avian influenza viruses (AIV) have been reported to cause infections in humans following avian-to-human transmission resulting in a wide range of clinical outcomes. A(H5N1) and A(H7N9) infections, that constitute the majority of human AIV cases, are responsible for severe infections leading to high mortality. The neuraminidase (NA) inhibitor oseltamivir is expected to play a major role for the control of AIV infections in humans. However, the emergence of resistance may compromise the impact of antiviral therapy. The objective of this manuscript is to review human cases of A(H5N1) and A(H7N9) infections for which mutations of oseltamivir resistance were detected. NA mutations rapidly occurred in a subtype-specific manner with H274Y and N294S substitutions predominating in A(H5N1) cases and the R292K substitution in A(H7N9) cases. Serious clinical outcomes and mortality were seen in most A(H5N1) and A(H7N9) cases despite oseltamivir therapy highlighting the need for improving antiviral strategies against these AIV.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 4 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 4 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 4 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 4 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 4 hours ago
[Go Top] [Close Window]


